The genetics of migraine

Lancet Neurology

Volumn 1, Issue 5, 2002, Pages 285-293

  Ducros, Anne ^a,b   Tournier Lasserve, Elisabeth ^b   Bousser, Marie Germaine ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CACNA1A PROTEIN, HUMAN;

AUTOSOMAL DOMINANT DISORDER; CACNA1A GENE; CHROMOSOME 19; CHROMOSOME 4; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FAMILIAL DISEASE; FAMILIAL HEMIPLEGIC MEMBRANE; GENE; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENE REPLICATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENOME ANALYSIS; GENOTYPE; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; X CHROMOSOME; CHROMOSOME; CHROMOSOME MAP; GENETIC SCREENING; GENETICS; MIGRAINE WITH AURA; MUTATION; NUCLEOTIDE SEQUENCE;

CALCIUM CHANNELS; CHROMOSOME MAPPING; CHROMOSOMES; DNA MUTATIONAL ANALYSIS; GENES; GENETIC SCREENING; HUMANS; MIGRAINE DISORDERS; MIGRAINE WITH AURA; MUTATION;

EID: 0038669623     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(02)00134-5     Document Type: Review

References (102)

1. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 8:1988;1-96.
2. Henry P., Michel P., Brochet B., Dartigues J.F., Tison S., Salamon R. A nationwide survey of migraine in France: prevalence and clinical features in adults. Cephalalgia. 12:1992;229-237.
3. Stewart W.F., Lipton R.B., Celentano D.D., Reed M.L. Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA. 267:1992;64-69.
4. Lipton R.B., Silberstein S.D., Stewart W.F. An update on the epidemiology of migraine. Headache. 34:1994;319-328.
5. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 41:2001;646-657.
6. Bruyn G.W. Intracranial arteriovenous malformation and migraine. Cephalalgia. 4:1984;191-207.
7. Pavlakis S.G., Phillips P.C., DiMauro S., De Vivo D.C., Rowland L.P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 16:1984;481-488.
8. Montagna P., Gallassi R., Medori R., et al. MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology. 38:1988;751-754.
9. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 46:2002;1019-1027.
10. Verin M., Rolland Y., Landgraf F., et al. New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry. 59:1995;579-585.
11. Chabriat H., Vahedi K., Iba-Zizen M.T., et al. Clinical spectrum of CADASIL: a study of 7 families. Lancet. 346:1995;934-939.
12. Ophoff R.A., Terwindt G.M., Vergouwe M.N., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 87:1996;543-552.
13. Ducros A., Campbell J.K. Familial hemiplegic migraine. Olesen J., Tfelt-Hansen P., Welch K.M.A. The headaches. 2nd edn. 2000;501-505 Lippincott-Raven, New York.
14. Ahmed M.A., Reid E., Cooke A., Arngrimsson R., Tolmie J.L., Stephenson J.B. Familial hemiplegic migraine in the west of Scotland: a clinical and genetic study of seven families. J Neurol Neurosurg Psychiatry. 61:1996;616-620.
15. Terwindt G.M., Ophoff R.A., Haan J., Frants R.R., Ferrari M.D. Familial hemiplegic migraine: a clinical comparison of families linked and unlinked to chromosome 19. Cephalalgia. 16:1996;153-155.
16. Ducros A., Denier C., Joutel A., et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 345:2001;17-24.
17. Haan J., Terwindt G.M., Ophoff R.A., et al. Is familial hemiplegic migraine a hereditary form of basilar migraine? Cephalalgia. 15:1995;477-481.
18. Haan J., Terwindt G.M., Bos P.L., Ophoff R.A., Frants R.R., Ferrari M.D. Familial hemiplegic migraine in The Netherlands. Clin Neurol Neurosurg. 96:1994;244-249.
19. Terwindt G.M., Ophoff R.A., Haan J., et al. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Neurology. 50:1998;1105-1110.
20. Fitzsimons R.B., Wolfenden W.H. Migraine coma: meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia. Brain. 108:1985;555-577.
21. Munte T.F., Muller-Vahl H. Familial migraine coma: a case study. J Neurol. 237:1990;59-61.
22. Elliott M.A., Peroutka S.J., Welch S., May E.F. Familial hemiplegic migraine, nystagmus, and cerebellar atrophy. Ann Neurol. 39:1996;100-106.
23. Echenne B., Ducros A., Rivier F., et al. Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics. 30:1999;214-217.
24. Young G.F., Leon-Barth C.A., Green J. Familial hemiplegic migraine, retinal degeneration, deafness, and nystagmus. Arch Neurol. 23:1970;201-209.
25. Joutel A., Ducros A., Vahedi K., et al. Genetic heterogeneity of familial hemiplegic migraine. Am J Hum Genet. 55:1994;1166-1172.
26. Ophoff R.A., van Eijk R., Sandkuijl L.A., et al. Genetic heterogeneity of familial hemiplegic migraine. Genomics. 22:1994;21-26.
27. Vahedi K., Denier C., Ducros A., et al. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology. 55:2000;1040-1042.
28. Russell M.B., Olesen J. The genetics of migraine without aura and migraine with aura. Cephalalgia. 13:1993;245-248.
29. Ziegler D.K., Hassanein R.S., Harris D., Stewart R. Headache in a non-clinic twin population. Headache. 14:1975;213-218.
30. Lucas R.N. Migraine in twins. J Psychosom Res. 21:1977;147-156.
31. Honkasalo M.L., Kaprio J., Winter T., Heikkila K., Sillanpaa M., Koskenvuo M. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache. 35:1995;70-78.
32. Larsson B., Bille B., Pedersen N.L. Genetic influence in headaches: a Swedish twin study. Headache. 35:1995;513-519.
33. Ziegler D.K., Hur Y.M., Bouchard T.J. Jr, Hassanein R.S., Barter R. Migraine in twins raised together and apart. Headache. 38:1998;417-422.
34. Gervil M., Ulrich V., Kyvik K.O., Olesen J., Russell M.B. Migraine without aura: a population-based twin study. Ann Neurol. 46:1999;606-611.
35. Gervil M., Ulrich V., Kaprio J., Olesen J., Russell M.B. The relative role of genetic and environmental factors in migraine without aura. Neurology. 53:1999;995-999.
36. Ulrich V., Gervil M., Kyvik K.O., Olesen J., Russell M.B. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol. 45:1999;242-246.
37. Waters W.E. Migraine: intelligence, social class, and familial prevalence. BMJ. 2:1971;77-81.
38. Steiner T.J., Guha P., Capildeo R., Rose F.C. Migraine in patients attending a migraine clinic: an analysis by computer of age, sex and family history. Headache. 20:1980;190-195.
39. Baier W.K. Genetics of migraine and migraine accompagnee: a study of eighty-one children and their families. Neuropediatrics. 16:1985;84-91.
40. Mochi M., Sangiorgi S., Cortelli P., et al. Testing models for genetic determination in migraine. Cephalalgia. 13:1993;389-394.
41. Bille B. A 40-year follow-up of school children with migraine. Cephalalgia. 17:1997;488-491.
42. Russell M.B., Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 311:1995;541-544.
43. Stewart W.F., Staffa J., Lipton R.B., Ottman R. Familial risk of migraine: a population-based study. Ann Neurol. 41:1997;166-172.
44. Russell M.B., Iselius L., Olesen J. Inheritance of migraine investigated by complex segregation analysis. Hum Genet. 96:1995;726-730.
45. Ulrich V., Russell M.B., Ostergaard S., Olesen J. Analysis of 31 families with an apparently autosomal-dominant transmission of migraine with aura in the nuclear family. Am J Med Genet. 74:1997;395-397.
46. Gambaro G., Anglani F., D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet. 355:2000;308-311.
47. Joutel A., Bousser M.G., Biousse V., et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 5:1993;40-45.
48. Gardner K., Barmada M.M., Ptacek L.J., Hoffman E.P. A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology. 49:1997;1231-1238.
49. Ducros A., Joutel A., Vahedi K., et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 42:1997;885-890.
50. De Waard M., Gurnett C.A., Campbell K.P. Structural and functional diversity of voltage-activated calcium channels. Narahashi T. Ion channels. 1996;41-87 Plenum Press, New York.
51. Moreno Davila H. Molecular and functional diversity of voltage-gated calcium channels. Ann N Y Acad Sci. 868:1999;102-117.
52. Lacinova L., Klugbauer N., Hofmann F. Low voltage activated calcium channels: from genes to function. Gen Physiol Biophys. 19:2000;121-136.
53. Perez-Reyes E. Three for T: molecular analysis of the low voltage-activated calcium channel family. Cell Mol Life Sci. 56:1999;660-669.
54. Plomp J.J., Vergouwe M.N., Van den Maagdenberg A.M., Ferrari M.D., Frants R.R., Molenaar P.C. Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation. Brain. 123:2000;463-471.
55. Bourinet E., Soong T.W., Sutton K., et al. Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci. 2:1999;407-415.
56. Zhuchenko O., Bailey J., Bonnen P., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 15:1997;62-69.
57. Battistini S., Stenirri S., Piatti M., et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology. 53:1999;38-43.
58. Carrera P., Piatti M., Stenirri S., et al. Genetic heterogeneity in Italian families with familial hemiplegic migraine. Neurology. 53:1999;26-33.
59. Ducros A., Denier C., Joutel A., et al. Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet. 64:1999;89-98.
60. Friend K.L., Crimmins D., Phan T.G., et al. Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM. Hum Genet. 105:1999;261-265.
61. Gardner K., Bernal O., Keegan M., et al. A new mutation in the chr19p calcium channel gene CACNL1A4 causing hemiplegic migraine with ataxia. Neurology. 52:(suppl. 2):1999;A115.
62. Kors E.E., Terwindt G.M., Vermeulen F.L., et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol. 49:2001;753-760.
63. Takahashi T., Igarashi S., Kimura T., et al. Japanese cases of familial hemiplegic migraine with cerebellar ataxia carrying a T666M mutation in the CACNA1A gene. J Neurol Neurosurg Psychiatry. 72:2002;676-677.
64. Yue Q., Jen J.C., Thwe M.M., Nelson S.F., Baloh R.W. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia. Am J Med Genet. 77:1998;298-301.
65. Denier C., Ducros A., Vahedi K., et al. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology. 52:1999;1816-1821.
66. Geschwind D.H., Perlman S., Figueroa K.P., Karrim J., Baloh R.W., Pulst S.M. Spinocerebellar ataxia type 6: frequency of the mutation and genotype- phenotype correlations. Neurology. 49:1997;1247-1251.
67. Kraus R.L., Sinnegger M.J., Glossmann H., Hering S., Striessnig J. Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem. 273:1998;5586-5590.
68. Hans M., Luvisetto S., Williams M.E., et al. Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci. 19:1999;1610-1619.
69. Kraus R.L., Sinnegger M.J., Koschak A., et al. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J Biol Chem. 275:2000;9239-9243.
70. Guida S., Trettel F., Pagnutti S., et al. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet. 68:2001;759-764.
71. Jen J., Wan J., Graves M., et al. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology. 57:2001;1843-1848.
72. Jun K., Piedras-Renteria E.S., Smith S.M., et al. Ablation of P/Q-type Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha(1A)- subunit. Proc Natl Acad Sci USA. 96:1999;15245-15250.
73. Fletcher C.F., Lutz C.M., O'Sullivan T.N., et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell. 87:1996;607-617.
74. Zwingman T.A., Neumann P.E., Noebels J.L., Herrup K. Rocker is a new variant of the voltage-dependent calcium channel gene CACNA1A. J Neurosci. 21:2001;1169-1178.
75. Ducros A., Joutel A., Vahedi K., Bousser M.G., Tournier-Lasserve E. Genotype-phenotype correlations in familial hemiplegic migraine. Olesen J., Bousser M.G. Genetics of headache disorders (frontiers in headache research). 2000;123-128 Lippincott-Raven, New York.
76. Russell M.B., Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 119:1996;355-361.
77. Sandor P.S., Mascia A., Seidel L., de Pasqua V., Schoenen J. Subclinical cerebellar impairment in the common types of migraine: a three-dimensional analysis of reaching movements. Ann Neurol. 49:2001;668-672.
78. Ambrosini A., de Noordhout A.M., Alagona G., Dalpozzo F., Schoenen J. Impairment of neuromuscular transmission in a subgroup of migraine patients. Neurosci Lett. 276:1999;201-203.
79. Ambrosini A., Maertens de Noordhout A., Schoenen J. Neuromuscular transmission in migraine: a single-fiber EMG study in clinical subgroups. Neurology. 56:2001;1038-1043.
80. Ambrosini A., de Noordhout A.M., Schoenen J. Neuromuscular transmission in migraine patients with prolonged aura. Acta Neurol Belg. 101:2001;166-170.
81. May A., Ophoff R.A., Terwindt G.M., et al. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet. 96:1995;604-608.
82. Nyholt D.R., Lea R.A., Goadsby P.J., Brimage P.J., Griffiths L.R. Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology. 50:1998;1428-1432.
83. Terwindt G.M., Ophoff R.A., van Eijk R., et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology. 56:2001;1028-1032.
84. Hovatta I., Kallela M., Farkkila M., Peltonen L. Familial migraine: exclusion of the susceptibility gene from the reported locus of familial hemiplegic migraine on 19p. Genomics. 23:1994;707-709.
85. Monari L., Mochi M., Valentino M.L., et al. Searching for migraine genes: exclusion of 290 cM out of the whole human genome. Ital J Neurol Sci. 18:1997;277-282.
86. Wieser T., Evers S., Gräber S., Günther M., Ziers S., Deufel T. Familial migraine: exclusion of common forms of migraine in four German pedigrees from the familial hemiplegic migraine region and the CACNL1A4 gene on chromosome 19p13. Olesen J., Bousser M.G. Genetics of headache disorders (frontiers in headache research). 2000;151-156 Lippincott-Raven, New York.
87. Lea R.A., Curtain R.P., Hutchins C., Brimage P.J., Griffiths L.R. Investigation of the CACNA1A gene as a candidate for typical migraine susceptibility. Am J Med Genet. 105:2001;707-712.
88. Jones K.W., Ehm M.G., Pericak-Vance M.A., Haines J.L., Boyd P.R., Peroutka S.J. Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus. Genomics. 78:2001;150-154.
89. Nyholt D.R., Dawkins J.L., Brimage P.J., Goadsby P.J., Nicholson G.A., Griffiths L.R. Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet. 7:1998;459-463.
90. Nyholt D.R., Curtain R.P., Griffiths L.R. Familial typical migraine: significant linkage and localization of a gene to Xq24-28. Hum Genet. 107:2000;18-23.
91. McCarthy L.C., Hosford D.A., Riley J.H., et al. Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics. 78:2001;135-149.
92. Wessman M., Kallela M., Kaunisto M.A., et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet. 70:2002;652-662.
93. Lea R.A., Shepherd A.G., Curtain R.P., et al. A typical migraine susceptibility region localizes to chromosome 1q31. Neurogenetics. 4:2002;17-22.
94. Montagna P. Molecular genetics of migraine headaches: a review. Cephalalgia. 20:2000;3-14.
95. Peroutka S.J., Wilhoit T., Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology. 49:1997;201-206.
96. Del Zompo M., Cherchi A., Palmas M.A., et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology. 51:1998;781-786.
97. Ogilvie A.D., Russell M.B., Dhall P., et al. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia. 18:1998;23-26.
98. Yilmaz M., Erdal M.E., Herken H., Cataloluk O., Barlas O., Bayazit Y.A. Significance of serotonin transporter gene polymorphism in migraine. J Neurol Sci. 186:2001;27-30.
99. Emin Erdal M., Herken H., Yilmaz M., Bayazit Y.A. Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Res Mol Brain Res. 94:2001;193-196.
100. Tzourio C., El Amrani M., Poirier O., Nicaud V., Bousser M.G., Alperovitch A. Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism. Neurology. 56:2001;1273-1277.
101. Lea R.A., Dohy A., Jordan K., Quinlan S., Brimage P.J., Griffiths L.R. Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics. 3:2000;35-40.
102. Kowa H., Yasui K., Takeshima T., Urakami K., Sakai F., Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 96:2000;762-764.